Loading clinical trials...
Loading clinical trials...
Glioblastoma multiform is one of the most invasive and deadly cancers that progresses rapidly and leads to death. Surgery with radiotherapy /chemotherapy, as a treatment approach is ineffective in som...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Royan Institute
Collaborators
NCT05902169 · Glioblastoma, Recurrent Glioblastoma, and more
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT05271240 · Glioblastoma, Glioblastoma Multiforme, and more
NCT05954858 · Glioma, Malignant, Glioblastoma, and more
Royan institute
Tehran
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions